WO2002039974A1 - Personal care compositions - Google Patents

Personal care compositions Download PDF

Info

Publication number
WO2002039974A1
WO2002039974A1 PCT/GB2001/005123 GB0105123W WO0239974A1 WO 2002039974 A1 WO2002039974 A1 WO 2002039974A1 GB 0105123 W GB0105123 W GB 0105123W WO 0239974 A1 WO0239974 A1 WO 0239974A1
Authority
WO
WIPO (PCT)
Prior art keywords
mycosporine
formula
methyl
added
stirring
Prior art date
Application number
PCT/GB2001/005123
Other languages
French (fr)
Inventor
Carole Llewellyn
Edward Galley
Original Assignee
Natural Environment Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Environment Research Council filed Critical Natural Environment Research Council
Priority to EP01996358A priority Critical patent/EP1341514A1/en
Priority to AU2002223081A priority patent/AU2002223081A1/en
Publication of WO2002039974A1 publication Critical patent/WO2002039974A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966Triazines or their condensed derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners

Abstract

Personal care compositions comprise sunscreening compounds which are mycosprorine-like amino acids (MAAs) of formula (I) in which R1 is:(a) H; or (b) a group of formula (II) -CH(R2 )CH2OH (II)in which R2 is H or Me; or(c) a group of formula III -CH(R3)COOH (III)in which R3 is H or an alkyl group containing 1 to 3 carbon atoms optionally substituted by hydroxy or an ester thereof; or(d) a group of formula IV -CR4 = CHMe (IV)in which R4 is H or -COOH; and R5 is methyl or a group of formula III as defined above or an ester thereof;and an additional organic or inorganic sunscreening agent.

Description

PERSONAL CARE COMPOSITIONS
The present invention relates to personal care compositions containing sunscreening compounds to counteract the deleterious effects of UV radiation. In one aspect of the present invention the personal care compositions are sunscreen compositions in which a sunscreening compound is used to protect the user's skin or hair from UV radiation. The term "sunscreen composition" is used herein to encompass sunscreening compositions such as moisturisers, day creams, tanning lotions and sunblockers which are intended for topical application to provide protection for the skin or hair against the sun's rays or other sources of ultraviolet (UV) radiation. Such sunscreen compositions may contain additional inorganic or organic sunscreening agents. In a further aspect of the present invention the personal care compositions are cosmetic/toiletries compositions containing a sunscreening compound to protect the compositions from the deleterious effects of exposure of the compositions to UV radiation. The term "cosmetic/toiletries composition" is used herein to encompass compositions intended for application to the skin or hair in which the sunscreen compounds are present to protect the compositions from the deleterious effects of exposure of the composition to UV radiation. Examples of cosmetic/toiletries composition include gels such as bath gels or shower gels, shampoos optionally containing conditioning agents and/or antidandruff agents, hair conditioners, liquid soaps, creams and lotions. Such compositions may be emulsions (oil-in-water emulsions or water-in-oil emulsions).
Most UV absorbing molecules that are permitted for use in the cosmetics, toiletries or healthcare field are oil soluble. There are very few water soluble UV absorbing molecules and there are no high efficiency (Extinction coefficient > 15000) water soluble molecules that absorb in the UVA region between 320 nm and 400 nm. Protection of the skin from these wavelengths is essential as these wavelengths are implicated in both direct UV mediated damage and indirect free radical damage. The deleterious effects of this on the skin include premature ageing, polymorphic light eruptions, skin cancer etc. The deleterious effects of UV radiation on cosmetic/toiletries compositions include colour fading, polymer breakdown leading to product structural instability, actives (eg vitamins) being destroyed etc.
One class of water soluble UV absorbing molecules has been disclosed, which are Mycosporine-like amino acids (MAAs). These compounds, which are derived from marine organisms, have been suggested for use as sunscreens.
However, the present inventors have discovered that MAAs are not suitable to be the sole suncreening agent in sunscreen compositions, but do offer benefits when used in conjunction with a conventional sunscreening agent, for example those listed in Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products, as last amended by Commission Directive 200/41/EC of 19 June 2000. In particular, the MAA and conventional sunscreen protect each other from degradation, whilst offering improved UV protection over that achieved with a conventional sunscreening agent alone.
The present invention provides personal care compositions comprising sunscreening compounds which are mycosprorine-like amino acids (MAAs) of formula I
Figure imgf000003_0001
in which Ri is: (a) H; or
(b) a group of formula II
-CH(R2 )CH2OH (II) in which R2 is H or Me; or (c) a group of formula III
-CH(R3)COOH (III) in which R3 is H or a straight or branched alkyl group containing 1 to 3 carbon atoms optionally substituted by hydroxy or an ester thereof; or (d) a group of formula IV -C(R4)=CHMe (IV) in which R4 is H or -COOH; and R5 is -CH3 or a group of formula III as defined above or an ester thereof; and an additional inorganic or organic sunscreening agent.
The compounds of formula I can exist as different tautomers. The present invention embraces all such tautomers and mixtures thereof. The compounds of formula I have an asymmetric carbon atom and can therefore exist as different enantiomers. The present invention embraces all such enantiomers and mixtures thereof. Compounds of formula I in which the group of formula II or III contains a chiral centre can exist as different stereoisomers. The present invention embraces all such stereoisomers and mixtures thereof.
In preferred compounds of formula I in which Ri is a group of formula III, R3 is H, -CH2OH, -CH(OH)Me or -CHMe2. In preferred compounds of formula I in which R5 is a group of formula III, R3 is H or -CH2OH.
Examples of particularly preferred compounds of formula I are=given in Table 1 below. Table 1
Figure imgf000005_0001
The mycosporine-like amino acids can be chemically synthesised or can be extracted from marine micro algae.
For chemical synthesis:
Compounds of formula I may be prepared by dihydroxylating a compound of formula V
Figure imgf000006_0001
with osmium tetraoxide catalysis or by epoxidation with sodium hypochlorite followed by hydrolysis.
Compounds of formula V may be prepared by the condensation of an amine of formula H2NR1 with a carbonylcyclohexenyl compound of formula VIA
Figure imgf000006_0002
or by the condensation of an amine of formula H2NR5 with a carbonylcyclohexenyl compound of formula VIB
Figure imgf000006_0003
Compounds of formula V may alternatively be prepared from carbonylcyclohexenyl compounds of formula VIA or VIB by reacting the compound of formula VIA or VIB with a chlorinating agent such as Vilsmeier's Reagent to give a compound of formula VILA or VIIB respectively
CL
Figure imgf000007_0001
which is then reacted with an amine of formula H2NR1 or H2NR5 respectively.
Compounds of formula VIA or VIB may be prepared by reacting a compound of formula VIII
Figure imgf000007_0002
Vn\
with an amine of formula NH2R5 or NH2Rι respectively. The compound of formula VIII may be prepared by the methylation of a compound of formula IX
Figure imgf000008_0001
^
The compound of formula IX may be prepared from a compound of formula X
Figure imgf000008_0002
X
by reaction with aqueous cupric chloride.
The compound of formula X may be prepared from 4-methoxybenzylchloride by a process involving the steps of silylation, Birch reduction and protodesilylation.
Compounds of formula I may be prepared by similar reactions to those described above in which the 1 ,2-diol substituent is introduced at an earlier stage. It may then be necessary to protect this diol substituent during subsequent stages of the synthesis by methods which are well known to those skilled in the art.
For extraction from marine micro-algae:
Axenic (bacteria free) micro-algae known to be rich in compounds of formula I (e.g. the dinoflagellate Gymnodinium catenatum) are grown using aseptic techniques in sterilised medium with appropriate trace metal, metal chelating compound and vitamin addition (e.g. f/2 medium or Plymouth Erdschreiber Medium). Photosynthetically active radiation is provided by Philip's daylight fluorescent tubes at a light intensity of 80 or 100μm"2 s"1 with supplementary UVR on 12:12 or a 18:6 h light: dark cycle. Temperature is kept at 15-20°C depending on species and optimum conditions of pH and turbulence are chosen. Cells are harvested during logarithmic growth phase using centrifugation or filtration.
The compounds of formula I can then be solvent extracted (e.g. cold tetrahydrofuran.methanol 20:80, v/v), concentrated and chromatographically purified from the cells to produce defined pure compounds. Alternatively cells can be digested and filtered to remove cell debris thus producing an extract containing the compound(s)
The personal care compositions of the present invention may contain 0.05 to 10% of the mycosporine-like amino acid by weight of the total composition. In compositions intended to be applied to the skin or hair to protect the skin or hair from the deleterious effects of exposure to UV radiation, the amount of mycosporine-like amino acid that may be present is preferably in the range 0.5 to 10%, more preferably 1 to 6%. ln compositions in which the mycosporine-like amino acid is present to protect the compositions from the deleterious effects of exposure to UV radiation, the amount of mycosporine-like amino acid present that may be present is preferably less than 1% by weight of the total composition, more preferably 0.05 to 0.6%, most preferably 0.3 to 0.5%.
The additional organic or inorganic sunscreening agent are preferably selected from those listed in Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products, as last amended by Commission Directive 200/41/EC of 19 June 2000, which is herein incorporated by reference. Suitable additional inorganic sunscreening agents include: a) Microfine titanium dioxide; b) Microfine zinc oxide; c) Boron nitride; d) Iron oxides; and e) Talcs
Examples of suitable additional organic sunscreening agents include:
a) para-aminobenzoic acids, esters and derivatives thereof, for example, 2- ethylhexyl para-dimethylaminobenzoate and the octyl ester of para- aminobenzoic acid; b) methoxycinnamate esters such as 2-ethylhexyl para-methoxycinnamate, 2- ethoxyethyl para-methoxycinnamate or α,β-di-(para-methoxycinnamoyl)-α'- (2-ethylhexanoyl)-glycerin; c) benzophenones such as oxybenzone; d) dibenzoylmethanes such as 4-(tert-butyl-4'-methoxydibenzoylmethane; e) 2-phenylbenzimidazole-5 sulfonic acid and its salts and disodium phenyl dibenzimidazole tetrasulfonate; f) alkyl-β,β-diphenylacrylates for example alkyl α-cyano-β,β-diphenylacrylates such as octocrylene; g) triazines such as 2,4,6-trianilino-(p-carbo-2-ethyl-hexyl-1-oxi)-1 ,3,5 triazine; h) camphor derivatives such as methylbenzylidene camphor and terphthalylidene dicamphor sulfonic acid; i) organic pigments sunscreening agents such as methylene bis-benzotriazole tetramethyl butylphenol; j) silicone based sunscreening agents such as drometrizole trisiloxane benzylidene malonate polysiloxane and dimethicodiethyl benzal malonate; and k) salicylates such as octyl salicylates. The additional sunscreening agent may be present in an amount of 0.1 to 25% by weight of the composition.
The sunscreening agents of the present invention may be incorporated into sunscreen products such as aqueous solutions or emulsions in a conventional manner. The emulsion may be an oil-in-water emulsion or a water-in-oil emulsion.
The oil phase of the water-in-oil or oil-in-water emulsions of the present invention may comprise for example:
a) hydrocarbon oils such as paraffin or mineral oils; b) waxes such as beeswax or paraffin wax; c) natural oils such as sunflower oil, apricot kernel oil, shea butter or jojoba oil; d) silicone oils such as dimethicone, cyclomethicone or cetyldimethicone; e) fatty acid esters such as isopropyl palmitate, isopropyl myristate or dioctylmaleate; I) fatty alcohols such as cetyl alcohol or stearyl alcohol; or g) mixtures thereof, for example, the blend of waxes available commercially under the trade name Cutina (Henkel).
In preferred water-in-oil compositions of the present invention the oil phase comprises 5 to 40%, more preferably 10 to 30% by weight of the composition. In preferred oil-in-water compositions of the present invention the oil phase comprises 5 to 30%, more preferably 10 to 20% by weight of the composition.
The emulsifiers used may be any emulsifiers known in the art for use in water-in-oil or oil-in-water emulsions. It has been found that particularly effective water-in-oil and oil-in-water sunscreen compositions can be prepared by using an emulsifier or mixture of emulsifiers selected from known cosmetically acceptable emulsifiers which include: a) sesquioleates such as sorbitan sesquioleate, available commercially for example under the trade name Arlacel 83 (ICI), or polyglyceryl-2- sesquioleate; b) ethoxylated esters of derivatives of natural oils such as the polyethoxylated ester of hydrogenated castor oil available commercially for example under the trade name Arlacel 989 (ICI); c) silicone emulsifiers such as silicone polyols available commercially for example under the trade name ABIL WS08 (Th. Goldschmidt AG); d) anionic emulsifiers such as fatty acid soaps e.g. potassium stearate and fatty acid sulphates e.g. sodium cetostearyl sulphate available commercially under the trade name Dehydag (Henkel); e) ethoxylated fatty alcohols, for example the emulsifiers available commercially under the trade name Brij (ICI); f) sorbitan esters, for example the emulsifiers available commercially under the trade name Span (ICI); g) ethoxylated sorbitan esters, for example the emulsifiers available commercially under the trade name Tween (ICI); h) ethoxylated fatty acid esters such as ethoxylated stearates, for example the emulsifiers available commercially under the trade name Myrj (ICI); i) ethoxylated mono-, di-, and tri-glycerides, for example the emulsifiers available commercially under the trade name Labrafil (Alfa Chem.); j) non-ionic self-emulsifying waxes, for example the wax available commercially under the trade name Polawax(Croda); k) ethoxylated fatty acids, for example, the emulsifiers available commercially under the trade name Tefose (Alfa Chem.); or
I) mixtures thereof.
The amount of emulsifier present in the emulsion compositions of the present invention is preferably in the range 1 to 10%.
The compositions of the present invention may additionally comprise other components which will be well known to those skilled in the art. These include, for example, emolients such as isopropyl myristate or triglycerides of fatty acids e.g. lauric triglyceride or capric/caprylic triglyceride, such as the triglyceride available commercially under the trade name Migliol 810 (Huls UK); moisturisers such as D- panthenol; humectants such as glycerin or 1 ,3-butylene glycol; antioxidants such as DL-α-tocopherylacetate or butylated hydroxytoluene; emulsion stabilising salts such as sodium chloride, sodium citrate or magnesium sulphate; film formers to assist spreading on the surface of the skin such as alkylated polyvinylpyrrolidone e.g. available commercially under the trade name Antaron (GAF); thickeners such as acrylic acid polymers e.g. available commercially under the trade name Carbopol (B.F. Goodrich) or modified celluloses e.g. hydroxyethylcellulose available commercially under the trade name Natrosol (Hercules) or alkylgalactomanans available under the trade name N-Hance; preservatives such as bronopol, sodium dehydroacetate, polyhexamethylenebiguanide hydrochloride, isothiazolone or diazolidinylurea; sequestering agents such as EDTA salts; perfumes and colourings.
The invention will be illustrated by the following examples which are given by way of example only. All percentages are by weight of the final composition. Examples 1 to 19 and 41 to 47 relate to compositions containing sunscreening compounds of formula I and an additional inorganic or organic sunscreening agent intended to protect the user's skin or hair from exposure to UV radiation (sunscreening compositions). Examples 20 to 40 are cosmetic/toiletries compositions containing sunscreening compositions of formula I and an additional organic and inorganic sunscreening agent to protect the compositions from deleterious effects of exposure to UV radiation.
Example 1
The following components are used to make a sunscreen composition of the present invention. No Description %
1 Cetyl Nonanoate 8.73
2 Light Liquid Paraffin WOM 14 7.82 3 Diglyceryl esters 5.3
4 Silicone Fluid 1000 4.8
5 Microcrystalline Wax 2.0
6 Ceteareth 2 phosphate 1.00
7 Cetyl Alcohol 0.5
8 Almond Oil BP 1973 0.5
9 Butylmethoxy dibenzoyl methane 1.2
10 Octyl methoxy cinnamate 1.0
11 Di octyl Butamido triazone 1.0
12 Butylated Hydroxytoluene 0.048
13 Acrylates cross polymer 0.38
14 Tetrapropoxy ethylenediamine 1.0
15 1 ,3-Butylene Glycol 4.8
16 Preservative qs
17 Sun Filter see table below
18 Water To 100%
Method
A Ingredients 1 to 12 are mixed and heated to 65°C. B Ingredients 13 to 18 are mixed and heated to 70°C to dissolve.
C Part A is added to part B with stirring, then homogenised for 20 minutes to give a water resistant sun lotion having an SPF of 6.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
1A Asterina-330 0.5
1 B Mycosporine-2-glycine 0.5
1C N-methyl mycosporine threonine 0.6
1 D Palythenic acid 0.4
1E Palythene 0.3
1 F Palythine 0.5
1G Palythinol 0.5 1 H Porphyra-334 0.5
11 Shinorine 0.5
U Usijirene 0.5
1 K Palythene serine 0.5
1 L N-methyl mycosporine serine 0.5
1M N-methyl mycosporine valine 0.5
Example 2
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Cetyl Nonanoate 8.73
2 Light Liquid Paraffin WOM 14 7.82
3 Diglyceryl esters 5.3
4 Silicone Fluid 1000 4.8
5 Microcrystalline Wax 1.9
6 Ceteareth 2 phosphate 1.00
7 Cetyl Alcohol 0.5
8 Almond Oil BP 1973 0.5
9 Butylmethoxy dibenzoyl methane 1.2
10 Octyl methoxy cinnamate 1.0
11 3 Benzylidene Camphor 2.0
12 Butylated Hydroxytoluene 0.05
13 Acrylates cross polymer 0.4
14 Tetrapropoxy ethylenediamine 1.2
15 1 ,3-Butylene Glycol 5.0
16 Preservative qs
17 Sun Filter See Table below
18 Water To 100% Method
A Ingredients 1 to 12 are mixed and heated to 65°C. B Ingredients 13 to 18 are mixed and heated to 70°C to dissolve. C Part A is added to part B with stirring, then homogenised for 20 minutes to give sunscreen compositions of the present invention having an SPF of 6.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
2A Asterina-330 0.5
2B Mycosporine-2-glycine 0.5
2C N-methyl mycosporine threonine 0.6
2D Palythenic acid 0.4
2E Palythene 0.3
2F Palythine 0.5
2G Palythinol 0.5
2H Porphyra-334 0.5
21 Shinorine 0.5
2J Usijirene 0.5
2K Palythene serine 0.5
2L N-methyl mycosporine serine 0.5
2M N-methyl mycosporine valine 0.5
Example 3
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Dioctyl Maleate 10.0
2 Diglyceryl esters 5.3
3 Silicone Fluid 1000 4.8
4 Microcrystalline Wax 1.9
5 Ceteareth 2 phosphate 1.0
6 Cetyl Alcohol 0.48 7 Almond Oil 0.48
8 Butylmethoxy dibenzoyl methane 2.9
9 Octyl methoxy cinnamate 1.9
10 Octocrylene 8.00 11 Butylated Hydroxytoluene 0.048
12 Acrylates cross polymer 0.4
13 Tetrapropoxy ethylenediamine 1.1
14 1 ,3-Butylene Glycol 4.8
15 Preservative qs 16 Sun Filter See Table below
17 Water To 100%
Method
A Ingredients 1 to 11 are mixed and heated to 65°C to melt together. B Ingredients 12 to 17 are mixed and heated to 70°C.
C Part A is added to part B slowly with stirring.
D Homogenise for 20 minutes to give sunscreen compositions of the present invention having an SPF of 25.
The amount of sunscreening compound of formula I used is as set out below.
Example Filter %
3A Asterina-330 5
3B Mycosporine-2-g lyci ne 5
3C N-methyl mycosporine threonine 5
3D Palythenic acid 5
3E Palythene 5
3F Palythine 5
3G Palythinol 5
3H Porphyra-334 5
31 Shinorine 5
3J Usijirene 5
3K Palythene serine 5 3L N-methyl mycosporine serine 5 3M N-methyl mycosporine valine 5
Example 4 The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Dioctyl Maleate 9.9
2 Diglyceryl esters 5.3
3 Silicone Fluid 1000 5
4 Microcrystalline Wax 2
5 Ceteareth 2 phosphate 1
6 Cetyl Alcohol 0.5
7 Almond Oil 0.5
8 Butylmethoxy dibenzoyl methane 3
9 Methylene bis-benzotriazole tetramethyl butylphenol 0.2
10 Octyl methoxy cinnamate 2
11 Butylated Hydroxytoluene 0.05
12 Acrylates cross polymer 0.4
13 Tetrapropoxy ethylenediamine 1.2
14 1 ,3-Butylene Glycol 5
15 Preservative qs
16 Sun Filter See Table below
17 Water To 100%
Method
A Ingredients 1 to 11 are mixed and heated to 65°C to melt together.
B Ingredients 12 to 17 are mixed and heated to 70°C.
C Part A is added to part B slowly with stirring.
D Homogenise for 20 minutes to give sunscreen compositions of the present invention having an SPF of 25. The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
4A Asterina-330 5
4B Mycosporine-2-glycine 5
4C N-methyl mycosporine threonine 5
4D Palythenic acid 5
4E Palythene 5
4F Palythine 5
4G Palythinol 5
4H Porphyra-334 5
41 Shinorine 5
4J Usijirene 5
4K Palythene serine 5
4L N-methyl mycosporine serine 5
4M N-methyl mycosporine valine 5
Example 5
The following components are used to make a sunscreen composition of the present invention.
Example Description %
1 Dioctyl Maleate 9.93
2 Diglyceryl esters 5.33
3 Silicone Fluid 1000 4.84
4 Microcrystalline Wax 1.94
5 Ceteareth 2 phosphate 0.97
6 Cetyl Alcohol 0.48
7 Almond Oil 0.48
8 Butylmethoxy dibenzoyl methane 2.91 9 2 Phenylbenzylimidazole 5-Sulphonic Acid
Sodium Salt 3
10 Octyl methoxy cinnamate 1.94 11 Butylated Hydroxytoluene 0.04
12 Acrylates cross polymer 0.38
13 Tetrapropoxy ethylenediamine 1.16
14 1 ,3-Butylene Glycol 4.84 15 Preservative qs
16 Sun Filter See Table below
17 Water To 100
Method A Ingredients 1 to 11 are mixed and heated to 65°C to melt together.
B Ingredients 12 to 17 are mixed and heated to 70°C.
C Part A is added to part B slowly with stirring.
D Homogenise for 20 minutes to give sunscreen compositions of the present invention having an SPF of 25.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
5A Asterina-330 5
5B Mycosporine-2-glycine 5
5C N-methyl mycosporine threonine 5
5D Palythenic acid 5
5E Palythene 5
5F Palythine 5
5G Palythinol 5
5H Porphyra-334 5
51 Shinorine 5
5J Usijirene 5
5K Palythene serine 5
5L N-methyl mycosporine serine 5
5M N-methyl mycosporine valine 5 Example 6
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Octyl Stearate 13.5
2 Isopropyl Myristate 5.0
3 Isohexadecane 3.0
4 Lecithin 0.1
5 Zinc Oxide Microfine 9.0
6 Titanium Dioxide MT100T 2.15
7 Polyglyceryl-3-Oleate 1.75
8 Cetyl Dimethicone Copolyol 1.35
9 1 ,3-Butylene Glycol 3.0
10 Magnesium Sulphate BP 0.75
11 Salt Pure Vacuum Dried 0.75
12 Preservative qs
13 Sun Filter See table below
14 Purified Water To 100
Method
A Ingredients 5 and 6 are dispersed into 1 , 2, 3, 4, 7 and 8 at 70°C with a rotor/stator homogeniser. B Ingredients 9 to 13 are dissolved in 14. C Part B is slowly added to part A with stirring. D The resulting emulsion is homogenised to achieve the required viscosity to give sunscreen compositions of the present invention having an SPF of 8.
The amount of sunscreening compound of formula I used is as set out below. Example Sun Filter % 6A Asterina-330 1.5
6B Mycosporine-2-glycine 1.5
6C N-methyl mycosporine threonine 1.5 6D Palythenic acid 1.5
6E Palythene 1.5
6F Palythine 1.5
6G Palythinol 1.5
6H Porphyra-334 1.5
61 Shinorine 1.5
6J Usijirene 1.5
6K Palythene serine 1.5
6L N-methyl mycosporine serine 1.5
6M N-methyl mycosporine valine 1.5
Example 7
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Cetyl Nonanoate 8.7
2 Light Liquid Paraffin WOM 7.8
3 Diglyceryl esters 5.3
4 Silicone Fluid 1000 4.8
5 Microcrystalline Wax 1.9
6 Ceteareth 2 phosphate 1.0
7 Cetyl Alcohol 0.5
8 Almond Oil BP 1973 0.5
9 Butylmethoxy dibenzoyl methane 1.2
10 Octyl Triazone 1.0
11 3 Benzylidene Camphor 2.0
12 Butylated Hydroxytoluene 0.05
13 Acrylates cross polymer 0.4
14 Tetrapropoxy ethylenediamine 1.2
15 1 ,3-Butylene Glycol 5.0
16 Preservative qs
17 Sun Filter See Table below 18 Water To 100%
Method
A Ingredients 1 and 12 are mixed and heated to 65°C. B Ingredients 13 to 18 are mixed and heated to 70°C to dissolve.
C Part A is added to part B with stirring, then homogenised for 20 minutes to give sunscreen compositions of the present invention having an SPF of 6.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
7A Asterina-330 0.5
7B Mycosporine-2-glycine 0.5
7C N-methyl mycosporine threonine 0.6
7D Palythenic acid 0.4
7E Palythene 0.3
7F Palythine 0.5
7G Palythinol 0.5
7H Porphyra-334 0.5
71 Shinorine 0.5
7J Usijirene 0.5
7K Palythene serine 0.5
7L N-methyl mycosporine serine 0.5
7M N-methyl mycosporine valine 0.5
Example 8
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Octyl Stearate 13.5 2 Isopropyl Myristate 5.0
3 Isohexadecane 3.0
4 Methylene bis benzotriazole tetramethyl butylphenol 2.0
5 Zinc Oxide Microfine 9.0
6 Titanium Dioxide MT100T 2.15
7 Polyglyceryl-3-Oleate 1.75 8 Cetyl Dimethicone Copolyol 1.35
9 1 ,3-Butylene Glycol 3.0
10 Mag Sulphate BP 0.75
11 Salt Pure Vacuum Dried 0.75
12 Preservative qs 13 Sun Filter See Table below
14 Purified Water To 100
Method
A Ingredients 5 and 6 are dispersed into 1 , 2, 3, 4, 7 and 8 with rotor/stator homogeniser B Ingredients 9 to 13 are dissolved into 14. C Part B is slowly added to part A with stirring.
D The resulting emulsion is homogenised to achieve the required viscosity to give sunscreen compositions of the present invention having an SPF of 8.
The amount of sunscreening compound of formula I used is as set out below.
No Sun Filter %
8A Asterina-330 1.5
8B Mycosporine-2-glycine 1.5
8C N-methyl mycosporine threonine 1.5
8D Palythenic acid 1.5
8E Palythene 1.5
8F Palythine 1.5
8G Palythinol 1.5
8H Porphyra-334 1.5
81 Shinorine 1.5
8J Usijirene 1.5
8K Palythine serine 1.5 8L N-methyl mycosporine serine 1.5
8M N-methyl mycosporine valine 1.5
Example 9 The following components are used to make a sunscreen composition of the present invention.
No Description %
I Octyl Stearate 13.5 2 Isopropyl Myristate 5.0
3 Isohexadecane 3.0
4 Di octyl Butamido triazone 2.0
5 Zinc Oxide Microfine 9.0
6 Titanium Dioxide MT100T 2.15 7 Polyglyceryl-3 Oleate 1.75
8 Cetyl Dimethicone Copolyol 1.35
9 1 ,3-Butylene Glycol 3.0
10 Magnesium Sulphate BP 0.75
I I Salt Pure Vacuum Dried 0.75 12 Preservative qs
13 Sun Filter See Table below'
14 Purified Water To 100
Method A Ingredients 5 and 6 are dispersed into 1 , 2, 3, 4, 7 and 8 with a rotor/stator homogeniser.
B Ingredients 9 to 13 are dissolved in 14.
C Part B is slowly added to part A with stirring.
D The resulting emulsion is homogenised to achieve the required viscosity to give sunscreen compositions of the present invention having an SPF of 8.
The amount of sunscreening compound of formula I used is as set out below. Example Sun Filter %
9A Asterina-330 1.5
9B Mycosporine-2-glycine 1.5
9C N-methyl mycosporine threonine 1.5
9D Palythenic acid 1.5
9E Palythene 1.5
9F Palythine 1.5
9G Palythinol 1.5
9H Porphyra-334 1.5
91 Shinorine 1.5
9J Usijirene 1.5
9K Palythine serine 1.5
9L N-methyl mycosporine serine 1.5
9M N-methyl mycosporine valine 1.5
Example 10
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Octyl Stearate 13.4
2 Isopropyl Myristate 4.9
3 Isohexadecane 3.0
4 Methyl Benzylidene Camphor 2.00
5 Titanium Dioxide MT100T 4.6
6 Zinc Oxide Microfine 14.0
7 Polyglyceryl-3 Oleate 175
8 Cetyl Dimethicone Copolyol 1.35
9 1 ,3-Butylene Glycol 3.0
10 Magnesium Sulphate BP 0J4
11 Salt Pure Vacuum Dried 0J4
12 Preservative qs 13 Sun Filter See Table below
14 Purified Water To 100
Method A Ingredients 5 and 6 are dispersed into 1 , 2, 3, 4, 7 and 8 with a rotor/stator homogeniser.
B Ingredients 9, 10, 11 , 12 and 13 are dissolved in 14.
C Part B is slowly added to part A with stirring.
D The emulsion is homogenised to viscosity to give sunscreen compositions of the present invention having an SPF of 30.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
10A Asterina-330 7
10B Mycosporine-2-glycine 7
10C N-methyl mycosporine threonine 10
10D Palythenic acid 10
10E Palythene 8
10F Palythine 7
10G Palythinol 7
10H Porphyra-334 7
101 Shinorine 7
10J Usijirene 7
10K Palythine serine 7
10L N-methyl mycosporine serine 7
10M N-methyl mycosporine valine 7
Example 11 The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Octyl Stearate 13.4 2 Isopropyl Myristate 4.9
3 Isohexadecane 3.0
4 Lecithin 0.1
5 Titanium Dioxide MT100T 4.5 6 Zinc Oxide Microfine 14.0
7 Polyglyceryl-3 Oleate 175
8 Cetyl Dimethicone Copolyol 1.35
9 1 ,3-Butylene Glycol 3.0
10 Magnesium Sulphate BP 074 11 Salt Pure Vacuum Dried 074
12 Preservative qs
13 Sun Filter See Table below
14 Purified Water To 100
Method
A Ingredients 5 and 6 are dispersed into 1 , 2, 3, 4, 7 and 8 at 70°C with a rotor/stator homogeniser. B Ingredients 9, 10, 11 , 12 and 13 are dissolved in 14. C Part B is slowly added to part A with stirring. D The emulsion is homogenised to viscosity to give sunscreen compositions of the present invention having an SPF of 30.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
11A Asterina-330 7
11 B Mycosporine-2-glycine 7
11 C N-methyl mycosporine threonine 10
11D Palythenic acid 10
11 E Palythene 8
11 F Palythine 7
11 G Palythinol 7
11 H Porphyra-334 7 111 Shinorine 7
11J Usijirene 7
11 K Palythine serine 7
11L N-methyl mycosporine serine 7
11M N-methyl mycosporine valine 7
Example 12
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 C12-C15 Alcohols Benzoate 12.0
2 Octyl methoxy cinnamate 3.8
3 Butylmethoxy dibenzoyl methane 3.0
4 Silicone Fluid 1000 2.0
5 Microcrystalline Wax 1.5
6 DL-A-Tocopheryl Acetate 0.2
7 PVP/Hexadecene Copolymer 175
8 Triclosan 0.20
9 Butylated Hydroxytoluene BP 0.05
10 Glyceryl-3 Glucose Distearate 2.00
11 Acr lates/Vinyl Ester Copolymer 0.14
12 Titanium Dioxide T 805 0.30
13 Sequestrene NA4 0.02
14 1 ,3-Butylene Glycol 5.00
15 Sorbithom TEP 0.50
16 Caustic Potash Soln 45% w/w 0.07
17 Preservative qs
18 Sun Filter See Table below
19 Water To 100
Method A Ingredients 1 to 10 are mixed and melted together at 60°C. B Ingredients 11 to 18 are mixed and dissolved together and heated to 65°C. C Part A is added to part B with stirring and homogenised for 20 minutes to give sunscreen compositions of the present invention having an SPF of
15.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
12A Asterina-330 2.5
12B Mycosporine-2-glycine 2.5
12C N-methyl mycosporine threonine 2.5
12D Palythenic acid 2.5
12E Palythene 2.5
12F Palythine 2.5
12G Palythinol 2.5
12H Porphyra-334 2.5
121 Shinorine 2.5
12J Usijirene 2.5
12K Palythine 2.5
12L N-methyl mycosporine serine 2.5
12M N-methyl mycosporine valine 2.5
Example 13
The following components are used to make a sunscreen composition of the present invention. No Description %
1 C12-C15 Alcohols Benzoate 8.08
2 Octyl methoxy cinnamate 1.41
3 Butylmethoxy dibenzoyl methane 0.80
4 4-Methylbenzylidene Camphor 0.50 5 Silicone Fluid 1000 2.02
6 Microcrystalline Wax 1.01
7 DL-A-Tocopheryl Acetate 0.20 8 Triclosan 0.20
9 Glyceryl-3 Glucose Distearate 2.02
10 Acrylates/Vinyl Ester Copolymer 0.10
11 1 ,3-Buytlene Glycol 5.05 12 Sequestrene NA4 0.02
13 Caustic Potash Soln 45% w/w 0.06
14 PVP/Hexadecene Copolymer 176
15 Preservative qs
16 Sun Filter See Table below 17 Water To 100
Method
A Ingredients 1 to 9 are melted together at 65°C. B Ingredients 10 to 16 are dispersed and dissolved into 17 and heated to 65°C.
C Part A is added to part B with stirring and homogenised for 20 minutes to give sunscreen compositions of the present invention having an SPF of 4.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
13A Asterina-330 0.5
13B Mycosporine-2-glycine 0.5
13C N-methyl mycosporine threonine 0.5
13D Palythenic acid 0.5
13E Palythene 0.5
13F Palythine 0.5
13G Palythinol 0.5
13H Porphyra-334 0.5
131 Shinorine 0.5
13J Usijirene 0.5
13K Palythine 0.5
13L N-methyl mycosporine serine 0.5 13M N-methyl mycosporine valine 0.5
Example 14
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 C12-C15 Alcohols Benzoate 12.8
2 Octyl methoxy cinnamate 2.97
3 Butylmethoxy dibenzoyl methane 1.98
4 4-Methylbenzylidene Camphor 0.99
5 Silicone Fluid 1000 1.98
6 Microcrystalline Wax 2.22
7 DL-A-Tocopheryl Acetate 0.19
8 PVP/Hexadecene Copolymer 1.73
9 Glyceryl-3 Glucose Distearate 1.98
10 Acrylates/Vinyl Ester Copolymer 0.09
11 Triclosan 0.19
12 1 ,3-Butylene Glycol 4.95
13 Sequestrene NA4 0.01
14 Caustic Potash Soln 45% w/w 0.05
15 Preservative QS
16 Sun Filter See Table below
17 Water To 100
Method
A Ingredients 1 to 9 are mixed and melted together at 65°C. B Ingredients 10, 11 , 12, 13, 14, 15, 16 are dissolved into 17 and heated to 65°C. C Part A is added to part B with stirring and homogenised for 20 minutes to give sunscreen compositions of the present invention having an SPF of 25. The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
14A Asterina-330 3
14B Mycosporine-2-glycine 3
14C N-methyl mycosporine threonine 3
14D Palythenic acid 3
14E Palythene 3
14F Palythine 3
14G Palythinol 3
14H Porphyra-334 3
141 Shinorine 3
14J Usijirene 3
14K Palythine 3
14L N-methyl mycosporine serine 3
14M N-methyl mycosporine valine 3
Example 15
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 1 ,3-Butylene Glycol 10.9
2 Sequestrene NA4 0.43 3 Citric Acid Monohydrate BP 0.04
4 Tetrapropoxy ethylenediamine 2.61
5 . Cetyl Nonanoate 19.6
6 Diglyceryl esters 12.0
7 Microcrystalline Wax 4.36 8 Light Liquid Paraffin WOM 14 14.9
9 Cetyl Alcohol 1.09
10 Silicone Fluid 1000 10.9 11 Butylmethoxy dibenzoyl methane 272
12 Octyl methoxy cinnamate 2.18
13 Ceteareth 2 phosphate 2.18
14 Theobroma Oil BP Deodorised 1.09 15 Butylated Hydroxytoluene BP 0.10
16 DL-A-Tocopheryl Acetate 0.43
17 Acrylates/Vinyl Ester Copolymer 0.87
18 Preservative qs
19 Sun Filter See Table below 20 Water To 100
Method A Ingredients 1 , 2, 3, 4, 17, 18 and 19 are dissolved into 20 and heated to 70°C. B Ingredients 5 to 16 are mixed and melted at 70°C.
C Part B is added to part A with stirring and homogenised for 20 minutes to give sunscreen compositions of the present invention having an SPF of 4.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
15A Asterina-330 0.5
15B Mycosporine-2-glycine 0.5
15C N-methyl mycosporine threonine 0.5
15D Palythenic acid 0.5
15E Palythene 0.5
15F Palythine 0.5
15G Palythinol 0.5
15H Porphyra-334 0.5
151 Shinorine 0.5
15J Usijirene 0.5
15K Palythine 0.5
15L N-methyl mycosporine serine 0.5 15M N-methyl mycosporine valine 0.5
Example 16
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Tetrapropoxy ethylenediamine 1.16
2 1 ,3-Butylene Glycol 4.85
3 Citric Acid Monohydrate BP PDR 0.01
4 Sequestrene NA4 0.19
5 Dioctyl Maleate 9.94
6 Diglyceryl esters 5.33
7 Microcrystalline Wax 1.94
8 Silicone Fluid 1000 4.85
9 Cetyl Alcohol 0.48
10 Octyl methoxy cinnamate 2.12
11 Butylmethoxy dibenzoyl methane 2.91
12 Butylated Hydroxytoluene BP 0.04
13 DL-A-Tocopheryl Acetate 0.19
14 Theobroma Oil BP 0.48
15 Ceteareth 2 phosphate 0.97
16 Acrylates Vinyl Ester Copolymer 0.38
17 Preservative qs
18 Sun Filter See Table below
19 Water To 100
Method
A Ingredients 1 , 2, 3, 4, 16, 17 and 18 are dissolved in 19 and heated to 70°C. B Ingredients 5 to 15 are mixed and heated to 70°C. C Part B is added to part A with stirring and then homogenised for 20 minutes to give sunscreen compositions of the present invention having an SPF of 20.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
16A Asterina-330 2.5
16B Mycosporine-2-glycine 2.5
16C N-methyl mycosporine threonine 2.5
16D Palythenic acid 2.5
16E Palythene 2.5
16F Palythine 2.5
16G Palythinol 2.5
16H Porphyra-334 2.5
161 Shinorine 2.5
16J Usijirene 2.5
16K Palythine 2.5
16L N-methyl mycosporine serine 2.5
16M N-methyl mycosporine valine 2.5
Example 17
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 C12-C15 Alcohols Benzoate 14.0
2 Octyl methoxy cinnamate 9.00
3 Butylmethoxy dibenzoyl methane 5.00
4 Silicone Fluid 1000 2.00
5 Microcrystalline Wax 2.50
6 DL-A-Tocopheryl Acetate 0.20
7 PVP/Hexadecene Copolymer 175
8 Propyl Hydroxybenzoate BP 0.10 9 Glyceryl-3 Glucose Distearate 2.50
10 Titanium Dioxide MT100T 3.00
11 TiO2 UV-Titan M212 2.00
12 Sequestrene NA4 0.02 13 Citric Acid Monohydrate BP PDR 0.05
14 1 ,3-Butylene Glycol 5.00
15 Keltrol 0.30
16 Preservatives qs
17 Sun Filter See Table below 18 Water To 100
Method
A Ingredients 1 to 9 are mixed and melted together at 65°C. B Ingredients 10 and 11 are dispersed into A with rotor/stator homogeniser. C Ingredients 12 to 17 are dissolved in 18.
D Part B is added to part C with mixing and homogenised for 20 minutes to give sunscreen compositions of the present invention having an SPF of
50.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
17A Asterina-330 10
17B Mycosporine-2-gJycine 10
17C N-methyl mycosporine threonine 10
17D Palythenic acid 10
17E Palythene 10
17F Palythine 10
17G Palythinol 10
17H Porphyra-334 10
171 Shinorine 10
17J Usijirene 10
17K Palythine 10 17L N-methyl mycosporine serine 10 17M N-methyl mycosporine valine 10
Example 18
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Dioctyl Maleate 10.0
2 Diglyceryl esters 5.3
3 Silicone Fluid 1000 4.8
4 Microcrystalline Wax 1.9
5 Ceteareth 2 phosphate 1.0
6 Cetyl Alcohol 0.48
7 Almond Oil 0.48
8 Butylmethoxy dibenzoyl methane 2.9
9 Octyl methoxy cinnamate 1.9
10 Dimethico diethylbenzalmalonate 8.00
11 Butylated Hydroxytoluene 0.048
12 Acrylates cross polymer 0.4
13 Tetrapropoxy ethylenediamine 1.1
14 1 ,3-Butylene Glycol 4.8
15 Preservative qs
16 Sun Filter See Table below
17 Water To 100%
Method
A Ingredients 1 to 11 mix and heat to 65°C to melt together.
B Ingredients 12 to 17 mix and heat to 70°C. C Part A is added to part B slowly with stirring. D Homogenise for 20 minutes to give sunscreen compositions of the present invention having an SPF of 25. The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
18A Asterina-330 5
18B Mycosporine-2-glycine 5
18C N-methyl mycosporine threonine 5
18D Palythenic acid 5
18E Palythene 5
18F Palythine 5
18G Palythinol 5
18H Porphyra-334 5
181 Shinorine 5
18J Usijirene 5
18K Palythine 5
18L N-methyl mycosporine serine 5
18M N-methyl mycosporine valine 5
Example 19
The following components are used to make a sunscreen composition of the present invention.
No Description %
1 Dioctyl Maleate 10.0
2 Diglyceryl esters 5.3
3 Silicone Fluid 1000 4.8
4 Microcrystalline Wax 1.9
5 Ceteareth 2 phosphate 1.0
6 Cetyl Alcohol 0.48
7 Almond Oil 0.48
8 Butylmethoxy dibenzoyl methane 2.9
9 Octyl methoxy cinnamate 1.9
10 Benzophenone 4 8.00
11 Butylated Hydroxytoluene 0.048
12 Acrylates cross polymer 0.4 13 Tetrapropoxy ethylenediamine 1.1
14 1 ,3-Butylene Glycol 4.8
15 Preservative qs
16 Sun Filter See Table below
17 Water To 100%
Method
A Ingredients 1 to 9 and 11 mix and heat to 65°C to melt together.
B IngredientslO and 12 to 17 mix and heat to 70°C. C Part A is added to part B slowly with stirring.
D Homogenise for 20 minutes to give sunscreen compositions of the present invention having an SPF of 25.
The amount of sunscreening compound of formula I used is as set out below.
Example Sun Filter %
19A Asterina-330 5
19B Mycosporine-2-glycine 5
19C N-methyl mycosporine threonine 5
19D Palythenic acid 5
19E Palythene 5
19F Palythine 5
19G Palythinol 5
19H Porphyra-334 5
191 Shinorine 5
19J Usijirene 5
19K Palythine 5
19L N-methyl mycosporine serine 5
19M N-methyl mycosporine valine 5
Examples 20 - 39
In these examples of cosmetic/toiletries compositions, a sunscreening compound of formula I and an additional organic or inorganic sunscreening agent are incorporated to protect the compositions from the deleterious effects of exposure to UV radiation. The amounts of the compounds of formula I to be used are given in Table A below.
Table A
Example UV Protector of Formula I %
A Asterina-330 0.1
B Mycosporine-2-glycine 0.5
C N-methyl mycosporine threonine 0.6
D Palythenic acid 0.4
E Palythene 0.3
F Palythine 0.05
G Palythinol 0.5
H Porphyra-334 0.2
I Shinorine 0.05
J Usijirene 0.5
K Palythine 0.5
L N-methyl mycosporine serine 0.2
M N-methyl mycosporine valine 0.4
Example 20 - Bath Gel
%w/
Sodium laureth sulfate 46
Disodium pareth-3 sulfosuccinate 25
Laurie fatty acids 11.5
Diethanolamine 11.5
Methyl gluceth-10 ethoxylated 2.5
Laneth-16 3
Preservative qs
Parfum qs
Benzophenone 4 0.5 UV protector See Table A
Method
Stage 1
The following materials are added to water in order using stirring:
Sodium laureth sulfate, Disodium pareth sulfosuccinate, lauric fatty acids, diethanolamine, methyl gluceth-10, laneth-16, benzophenone 4 and UV Protector.
Stage 2
Maintaining the stirring, the bulk is heated to 65°C. when uniform, the bulk is cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform.
Example 21 - Bath Gel
%w/w
Aqua 75.5
Sodium lauryl sulfate 20 Cocamidopropyl betaine 1.5
Sodium chloride 0.2
PEG-6 Cocamide 1
Dipropylene glycol 0.25
PEG-18 glyceryl oleate/cocoate 0.5 Preservative qs
Parfum qs
Benzophenone 4 0.5
UV protector See Table A Method
Stage 1
The following materials are added to the water in order using stirring:
Sodium lauryl sulfate, sodium chloride, PEG-6 cocamide, dipropylene glycol,
PEG-18, cocamidopropyl betaines, benzophenone 4 and UV protector.
Stage 2
Maintaining stirring, the bulk is heated to 65°C. Once uniform, the bulk is cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform.
Example 22 - Shower Gel
%w/w Aqua 77
Sodium lauryl sulfate 10.5
Cocoamphocarboxypropionate 6
Sodium lauroyl sarcosinate 3
Cocamide MEA 3 Preservative qs
Parfum qs
Benzophenone 4 0.5
UV protector See Table A
Method
Stage 1
The following materials are added to the water in order with stirring: Sodium lauryl sulfate, cocoamphocarboxypropionate, sodium lauroyl sarcosinate, cocamide MEA, benzophenone 4 and UV protector
Stage 2 Maintaining stirring, the bulk is heated to 65°C. Once uniform, the bulk is cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform.
Example 23 - Shower Gel
%w/w Aqua 75
Sodium lauryl sulfate 20
Cocamidopropyl betaine 1.5
Sodium chloride 0.2
PEG-6 Cocamide 1 Dipropylene glycol 0.25
PEG-18 glyceryl oleate/cocoate 0.5
PEG-40 hydrogenated castor oil 0.5
Polyquaternium-7 0.04
PEG-7 glyceryl cocoate 0.5 Tetrasodium EDTA 0.02
Preservative qs
Benzophenone 4 0.5
UV protector see Table A Method
Stage 1
The following materials are added to the water in order with stirring: polyquaternium-7, tetrasodium EDTA, sodium lauryl sulfate, sodium chloride, PEG-6, dipropylene glycol, PEG-18, PEG-40, PEG-7, cocamidopropyl betaines, benzophenone 4 and UV protector.
Stage 2 Maintaining stirring, the bulk is heated to 65°C. Once uniform, the bulk is cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform.
Example 24 - Shampoo
%w/w
Aqua 84.36 Ammonium lauryl sulfate 5.04
Lauroyl sarcosine 5
Lauramide DEA 5
Tetrasodium EDTA 0.1
Preservative qs Parfum qs
Benzophenone 4 0.5
UV protector see Table A
Method
Stage 1
The following materials are added to the water in order with stirring: tetrasodium EDTA, ammonium lauryl sulfate, lauroyl sarcosinate, lauramide DEA, benzophenone 4 and UV protector
Stage 2 Maintaining stirring, the bulk is heated to 65°C. Once uniform, the bulk is cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product was stirred until cool and uniform.
Example 25 - Shampoo
%w/w
Aqua 87 Sodium lauryl sulfate 7.8
Sodium chloride 0.8
Cocamidopropyl betaine 0.75
Glycol distearate 0.8
Laureth-3 2 Preservative qs
Parfum qs
Benzophenone 4 0.5
UV protector See Table A
Method
Stage 1
The following materials are added to the water in order with stirring: sodium lauryl sulfate, sodium chloride, laureth-3, cocamidopropyl betaines, benzophenone 4 and UV protector. Stage 2
Maintaining stirring, the bulk is heated to 65°C. Glycol distearate is then added and dispersed. Once uniform, the bulk was cooled with constant stirring to below
35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform and the pearl had set up.
Example 26 - Shampoo and Conditioner
%w/w
Aqua 67.4 Alpha olefin sulfonate 25
Cocamide DEA 2
Lauramide DEA 1
Oleamide MIPA 1.5
Cocamidopropyl betaine 2 Oleth-3 phosphate 0.1
Lauric acid 0.25
Sodium chloride 0.25
Preservative qs
Parfum qs Benzophenone 4 0.5
UV protector See Table A
Method
Stage 1
The following materials are added to the water in order with stirring: alpha olefin sulfonate, cocamide DEA, lauramide DEA, oleamide MIPA, cocamidopropyl betaine, lauric acid, oleth-3 phosphate, benzophenone 4 and UV protector.
Stage 2
Maintaining stirring, the bulk is heated to 65°C. Once uniform, the bulk is cooled with constant stirring to below 35°C.
Stage 3 The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform.
Example 27 - Shampoo and Conditioner
%w/w
Aqua 82.5
Sodium lauryl sulfate 8
Cocamidopropyl betaine 2
Ethylene glycol monostearate 3 Dimethicone 3.5
Hydroxypropyl guar hydroxypropyltrimonium chloride 0.4
Citric acid 0.02
Tetrasodium EDTA 0.05
Preservative qs Parfum qs
Benzophenone 4 0.5
UV protector See Table A
Method
Stage 1
The following materials are added to the water in order with stirring: hydroxypropyl guar hydroxypropyltrimonium chloride, citric acid, tetrasodium EDTA, sodium lauryl sulfate, cocamidopropyl betaine, ethylene glycol monostearate, benzophenone 4 and UV protector.
Stage 2
Maintaining stirring, the bulk is heated to 75°C. Once uniform, dimethicone is added and dispersed. The bulk is then cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform.
Example 28 - Anti-dandruff Shampoo %w/w
Aqua 76.85
Sodium N-methyl-N-myristoyl-taurate 13.65
Laneth-10 acetate 1
Coconut oil diethanolamine condensate 5 Zinc pyrithione (dispersion) 2
Preservative qs
Parfum qs
Benzophenone 4 0.5
UV Protector See Table A
Method
Stage 1
The following materials are added to the water in order with stirring: sodium N-methyl-N-myristoyl-taurate, laneth-10, coconut oil, zinc pyrithione dispersion, benzophenone 4 and UV protector. Stage 2
Maintaining stirring, the bulk is heated to 65°C. Once uniform, the bulk is cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform.
Example 29 - Antidandruff Shampoo
%w/w
Aqua 82.5
Sodium lauryl sulfate 8
Cocamidopropyl betaine 2 Ethylene glycol monostearate 3
Dimethicone 3.5
Hydroxypropyl guar hydroxypropyltrimonium chloride 0.4
Citric acid 0.02
Tetrasodium EDTA 0.05 Zinc pyrithione (dispersion) 1
Preservative qs
Parfum qs
Benzophenone 4 0.5
UV Protector See Table A
Method
Stage 1
The following materials are added to the water in order with stirring: hydroxypropyl guar hydroxypropyltrimonium chloride, citric acid, tetrasodium EDTA, sodium lauryl sulfate, cocamidopropyl betaine, ethylene glycol monostearate, zinc pyrithione dispersion, benzophenone 4 and UV protector Stage 2
Maintaining stirring, the bulk is heated to 75°C. Once uniform, dimethicone is added and dispersed. The bulk is then cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform. Example 30 - Liquid Soap
%w/w
Aqua 83.2
Magnesium aluminium silicate 1
Potassium hydroxide 2 Propylene glycol 2.5
Sodium laureth sulfate 1.8
Oleic acid 9
Preservative qs
Parfum qs Benzophenone 4 0.5
UV Protector See Table A
Method
Stage 1
Magnesium aluminium silicate is added to the water and dispersed using stirring then potassium hydroxide is added and dispersed. Propylene glycol, sodium laureth sulfate, oleic acid, benzophenone 4 and the UV protector are then added. Stage 2
Maintaining the stirring, the bulk is heated to 75°C, giving enough time for the oleic acid to saponify. The bulk is then cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform.
Example 31 - Beaded Shower Gel
%w/w
Aqua 76.5
Sodium lauryl sulfate 9.5
Citric acid 0.02 Tetrasodium EDTA 0.05
Mica beads 0.1
Acrylates copolymer 6
PEG-40 hydrogenated castor oil 0.5
PEG-6 Cocamide 1 Dipropylene glycol 0.25
PEG-18 glyceryl oleate/cocoate 0.5
Preservative qs
Parfum qs
Benzophenone 4 0.5 UV Protector See Table A
Method
Stage 1 The following materials are added to the water in order with stirring: citric acid, tetrasodium EDTA, sodium lauryl sulfate, PEG-40, PEG-6, PEG-18, acrylates copolymer, dipropylene glycol, benzophenone 4 and UV Protector Stage 2
Maintaining stirring, the bulk is heated to 70°C. Once uniform, the bulk is then cooled with constant stirring to below 35°C.
Stage 3
The preservative, perfume and mica are added and the product is made to weight with purified water. The product is stirred until cool and uniform.
Example 32 - Oil-in-Water Emulsion
%w/w
Aqua 62.5
Carbomer 940 0.35
1 ,3-Butylene glycol 2 Tetrasodium EDTA 0.05
Potassium Hydroxide 0.06
Polysorbate 80 1
Paraffinum liquidum 18
Preservative qs Octyl Methoxycinnamate 0.5
UV protector See Table A
Method
Stage 1
EDTA is dispersed in the water using stirring. Carbomer is then added and hydrated using homogenisation for 30 minutes. The UV protector is added and dispersed using stirring.
Butylene glycol and polysorbate 80 are then added and mixed until uniform using stirring. This phase is then heated to 70°C. Stage 2
The paraffinum liquidum is weighed into a separate vessel and heated to 70°C.
Stage 3
The oil phase is added to the aqueous phase and an emulsion is formed using high shear homogenisation for 10 minutes. The potassium hydroxide and octyl methoxycinnamate is then added and the shear was maintained for a further 5 minutes.
Stage 4
The emulsion is cooled to below 35°C using stirring. The preservative is then added and the product is made to weight with purified water. The emulsion is stirred until cool and uniform.
Example 33 - Oil-in-Water Emulsion
%w/w
Aqua 76.5
Glycerin 5 Paraffinium liquidum 5
Dicaprylyl maleate 3
Petrolatum 3
Cetyl alcohol 2
Steareth-2 1.5 Glyceryl stearate 1.5
Steareth-21 1
Sodium citrate 0.06
Citric acid 0.02
Hydroxyethyl cellulose 0.3 Tetrasodium EDTA 0.05
Preservative qs
Parfum qs Octyl methoxycinnamte 0.5
UV Protector See Table A
Stage 1 EDTA, citric acid, sodium citrate and glycerin are dispersed in the water using stirring. For sample 1 , the hydroxyethyl cellulose is then added and hydrated using homogenisation for 5 minutes. The UV Protector is added and dispersed with stirring. This phase was then heated to 70°C.
Stage 2
The oils and waxes are mixed in a separate vessel and heated to 70°C until melted.
Stage 3 The oil phase is added to the aqueous phase and an emulsion is formed using high shear homogenisation for 10 minutes and the octyl methoxycinnamate is added.
Stage 4 The emulsion is cooled to below 35°C using stirring. The preservative and perfume are then added and the product is made to weight with purified water.
The emulsion is stirred until cool and uniform.
Example 34 - Water-in-Oil Emulsion %w/w
Aqua 76.43
1 ,3-Butylene glycol 5
Sodium chloride 1
Cetyl dimethicone copolyol 1.5 Sorbitan isostearate 0.5
Stearic acid 0.05
Paraffinum liquidum 15 Butylated hydroxytoluene 0.02
Preservative qs
Octyl methoxycinnamate 0.5
UV Protector See Table A
Method
Stage 1
Sodium chloride, butylene glycol and UV Protector are added to the water using stirring. This phase is heated to 70°C maintaining stirring.
Stage 2
The oil phase is mixed and heated to 70°C until melted and uniform.
Stage 3
Using high speed stirring, the aqueous phase is slowly added to the oil phase and stirred until emulsified and uniform. The emulsion is then transferred to a homogeniser and high shear was applied for 5 minutes and then the octyl methoxycinnamate is added.
Stage 4
The emulsion is cooled to below 35°C with stirring and the preservative is added.
Stirring continued until cool and uniform.
Example 35 - Cold Cream
%w/w
Aqua 68.5
Magnesium aluminium silicate 1
Synthetic beeswax 1.5 Fatty acid ester 1.5
Paraffinum liquidum 20 Sorbitan monopalmitate fatty acid ester 3.5
Polysorbate 60 3.5
Preservative qs
Octyl methoxycinnamate 0.5 UV Protector See Table A
Method
Stage 1 Magnesium aluminium silicate is added to the water and dispersed using stirring, followed by the addition and dispersion of polysorbate 60 and the UV protector. This phase is heated to 70°C maintaining stirring.
Stage 2 The oil phase is mixed in a separate vessel and heated to 70°C until melted and uniform.
Stage 3
Maintaining the temperature of both phases, the oil phase is added to the aqueous phase and an emulsion is formed using high shear homogenisation for 10 minutes and the octyl methoxycinnamate added.
Stage 4
The emulsion is cooled to below 35°C using stirring. The preservative is then added and the product is made to weight with purified water. The emulsion is stirred until cool and uniform.
Example 36 - Body Lotion
%w/w Aqua 68.47
Carbomer 940 0.3
Sodium hydroxide 0.028 Glycerine 5
Glyceryl monostearate and polyoxyethylene 4
Stearate fatty acid ester 2
Paraffinum liquidum 15 Cholesterol 5
Oleyl alcohol 2
Tetrasodium EDTA 0.05
Preservative qs
Octyl methoxycinnamate 0.5 UV Protector See Table A
Method
Stage 1 EDTA is dispersed in the water using stirring. The Carbomer is then added and hydrated using homogenisation for 30 minutes. Glycerin and the UV protector are then added and stirred until uniform using stirring. This phase is then heated to 70°C.
Stage 2
The oil phase is mixed in a separate vessel and heated to 70°C until melted and uniform.
Stage 3 The oil phase is added to the aqueous phase and an emulsion is formed using high shear homogenisation for 10 minutes. Sodium hydroxide and octyl methoxycinnamate are then added and the shear is maintained for a further 5 minutes. Stage 4
The emulsion is cooled to below 35°C using stirring. The preservative is then added and the product is made to weight with purified water. The emulsion is stirred until cool and uniform.
Example 37 - Hair Conditioner
%w/w
Aqua 89.3
Cetyl trimethyl ammonium chloride 1.5 Alumina 0.5
Petrolatum 1.5
Glyceryl stearate 0.2
Acetylated lanolin alcohol 2
Mineral oil (and) lanolin alcohol 2 Stearyl alcohol 2.5
Preservative qs
Parfum qs
Octyl methoxycinnamate 0.5
UV protector See Table A
Method
Stage 1
The materials are added to the water in the order shown above (excluding the parfum and preservative) with stirring. With constant stirring, the bulk is heated to 70°C until all materials are dispersed, melted and uniform.
Stage 2
The product was cooled to below 35°C using stirring. The preservative and perfume are then added and the product is made to weight with purified water. The product is then stirred until cool and uniform. Example 38 - Hair Conditioner
%w/w
Aqua 89.5
Cetyl alcohol 4 Cocamide MEA 2
Stearamidopropyl dimethylamine 1
Centrimonium chloride 0.5
Citric acid 0.02
Lactic acid 0.4 hydroxyethyl cellulose 0.5
Tetrasodium EDTA 0.05
Preservative qs
Parfum qs
Octyl methoxycinnamate 0.5 UV Protector See Table A
Method
Stage 1 EDTA, citric acid and lactic acid were added to the water and dispersed with stirring. The hydroxyethyl cellulose was added and hydrated using a homogeniser for 5 minutes and the UV protector and octyl methoxycinnamate was then added.
The other materials were added to the water in the order shown above (excluding the parfum and preservative) with stirring. With constant stirring, the bulk was heated to 70°C until all materials were dispersed, melted and uniform.
Stage 2 The product was cooled to below 35°C using stirring. The preservative and perfume were then added and the product was made to weight with purified water. The product was then stirred until cool and uniform. Example 39 - Fluid Foundation
%w/w
Aqua 61
Carbomer 941 0.5
Lanolin oil 5
Paraffinum liquidum 3.5
Stearyl alcohol (and) ceteareth-20 condensate 3
Triethanolamine 0.5
Ethanol 26
Tetrasodium EDTA 0.02
Pigments qs
Preservative qs
Octyl methoxycinnamate 0.5
UV protector See table A
Method
Stage 1
EDTA is added to the water and dispersed with stirring. The carbomer is added and hydrated using a homogeniser for 30 minutes and then the UV protector is added. This phase was then heated to 70°C.
Stage 2
The oil phase is mixed in a separate vessel and heated to 70°C until melted and uniform.
Stage 3
The oil phase is added to the aqueous phase and an emulsion is formed using high shear homogenisation for 10 minutes. Sodium hydroxide and octyl methoxycinnamate is then added and the shear is maintained for a further 5 minutes. Maintaining the shear, the pigments are slowly added and dispersed. The emulsion is sheared until uniform. Stage 4
The emulsion is then cooled to below 35°C with stirring. The preservative is added and the product is made to weight with purified water.
Example 40 - Body Scrub
%w/w
Aqua 65.5
Lauroamphodiacetate 8 sodium lauryl sulfate 6 Hexylene glycol 6
PEG-40 castor oil 4
Polysorbate 80 1.5
Cetyl acetate 1
Acetylated lanolin alcohol 0.5 Methyl gluceth-20 2
Glycerin 4
Polyethylene 1
Parfum qs
Preservative qs Octyl methoxycinnamate 0.5
UV Protector See Table A
Method
Stage 1
The materials (excluding the parfum, preservative and polyethylene) are added to the water in order with stirring. This is heated to 70°C, maintaining the stirring. The bulk is stirred until uniform.
Stage 2
Maintaining the stirring the product is cooled to 35°C. The parfum, preservative and polyethylene are added and the product is made to weight with purified water. The product is stirred until the polyethylene is evenly distributed and the product is uniform.
Examples 41 - 45
In these examples of hair toiletry compositions, a sunscreening compound of formula I and an additional organic or inorganic sunscreening agent are incorporated to protect the hair from the deleterious effects of exposure to UV radiation. This damage is noticed as both natural and artificial hair colour fading, increased brittleness, dullness and tendency to split, loss of shine, feel or control and damage to the natural proteins and lipids in the hair. The amounts of the compounds of formula I to be used are given in Table B below.
Table B
Example UV Protector of Formula I %
A Asterina-330 0.1
B Mycosporine-2-glycine 1.5
C N-methyl mycosporine threonine 1.0
D Palythenic acid 0.4
E Palythene 0.3
F Palythine 2.5
G Palythinol 0.5
H Porphyra-334 1.2
I Shinorine 0.1
J Usijirene 0.5
K Palythine 0.5
L N-methyl mycosporine serine 1.2
M N-methyl mycosporine valine 0.4 Example 41 - Shampoo
%w/w
Aqua to 100
Sodium lauryl sulfate 7.8
Sodium chloride 0.8
Cocamidopropyl betaine 0.75
Glycol distearate 0.8
Laureth-3 2
Preservative qs
Parfum qs
Benzophenone 4 0.5
UV protector See Table B
Method
Stage 1
The following materials are added to the water in order with stirring: sodium lauryl sulfate, sodium chloride, laureth-3, cocamidopropyl betaines, benzophenone 4 and UV protector.
Stage 2
Maintaining stirring, the bulk is heated to 65°C. Glycol distearate is then added and dispersed. Once uniform, the bulk was cooled with constant stirring to below
35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform and the pearl had set up. Example 42 - Shampoo and Conditioner
%w/w
Aqua to 100
Alpha olefin sulfonate 25 Cocamide DEA 2
Lauramide DEA 1
Oleamide MIPA 1.5
Cocamidopropyl betaine 2
Oleth-3 phosphate 0.1 Lauric acid 0.25
Sodium chloride 0.25
Preservative qs
Parfum qs
Benzophenone 4 0.5 UV protector See Table B
Method
Stage 1 The following materials are added to the water in order with stirring: alpha olefin sulfonate, cocamide DEA, lauramide DEA, oleamide MIPA, cocamidopropyl betaine, lauric acid, oleth-3 phosphate, benzophenone 4 and UV protector.
Stage 2
Maintaining stirring, the bulk is heated to 65°C. Once uniform, the bulk is cooled with constant stirring to below 35°C.
Stage 3 The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform. Example 43 - Shampoo and Conditioner
%w/w
Aqua to 100
Sodium lauryl sulfate 8
Cocamidopropyl betaine 2
Ethylene glycol monostearate 3
Dimethicone 3.5
Hydroxypropyl guar hydroxypropyltrimonium chloride 0.4
Citric acid 0.02
Tetrasodium EDTA 0.05
Preservative qs
Parfum qs
Benzophenone 4 0.5
UV protector See Table B
Method
Stage 1 The following materials are added to the water in order with stirring: hydroxypropyl guar hydroxypropyltrimonium chloride, citric acid, tetrasodium EDTA, sodium lauryl sulfate, cocamidopropyl betaine, ethylene glycol monostearate, benzophenone 4 and UV protector.
Stage 2
Maintaining stirring, the bulk is heated to 75°C. Once uniform, dimethicone is added and dispersed. The bulk is then cooled with constant stirring to below 35°C.
Stage 3
The preservative and perfume are added and the product is made to weight with purified water. The product is stirred until cool and uniform. Example 44 - Hair Conditioner
%w/w
Aqua to 100 Cetyl trimethyl ammonium chloride 1.5
Alumina 0.5
Petrolatum 1.5
Glyceryl stearate 0.2
Acetylated lanolin alcohol 2 Mineral oil (and) lanolin alcohol 2
Stearyl alcohol 2.5
Preservative qs
Parfum qs
Benzophenone 4 0.5 UV protector See Table B
Method
Stage 1 The materials are added to the water in the order shown above (excluding the parfum and preservative) with stirring. With constant stirring, the bulk is heated to 70°C until all materials are dispersed, melted and uniform.
Stage 2 The product was cooled to below 35°C using stirring. The preservative and perfume are then added and the product is made to weight with purified water. The product is then stirred until cool and uniform. Example 45 - Hair Conditioner
%w/w
Aqua to 100
Cetyl alcohol 4 Cocamide MEA 2
Stearamidopropyl dimethylamine 1
Centrimonium chloride 0.5
Citric acid 0.02
Lactic acid 0.4 hydroxyethyl cellulose 0.5
Tetrasodium EDTA 0.05
Preservative qs
Parfum qs
Benzophenone 4 0.5 UV Protector See Table B
Method
Stage 1 EDTA, citric acid and lactic acid were added to the water and dispersed with stirring. The hydroxyethyl cellulose was added and hydrated using a homogeniser for 5 minutes and the UV protector was then added.
The other materials were added to the water in the order shown above (excluding the parfum and preservative) with stirring. With constant stirring, the bulk was heated to 70°C until all materials were dispersed, melted and uniform.
Stage 2
The product was cooled to below 35°C using stirring. The preservative and perfume were then added and the product was made to weight with purified water. The product was then stirred until cool and uniform. Example 46 and 47
In these examples of skincare and cosmetic compositions, a sunscreening compound of formula I and an additional organic or inorganic sunscreening agent are incorporated to protect the skin from the deleterious effects of exposure to UV radiation. This damage is noticed as the generation of harmful reactive oxygen species in the skin, damage to cellular structures such as langerhan cells, keratinocytes and melanocytes, damage to collagen and elastin resulting in premature ageing, damage to DNA, mitochondria and other intracellular constituents, and damage to the natural proteins and lipids in the skin. The amounts of the compounds of formula I to be used are given in Table C below. Table C
Example UV Protector of Formula I %
A Asterina-330 0.1
B Mycosporine-2-glycine 1.5
C N-methyl mycosporine threonine 1.0
D Palythenic acid 0.4
E Palythene 5.0
F Palythine 2.5
G Palythinol 0.5
H Porphyra-334 1.2
I Shinorine 0.3
J Usijirene 7.5
K Palythine 0.5
L N-methyl mycosporine serine 10.0
M N-methyl mycosporine valine 0.4
Example 46 - Dav Cream
%w/w
Aqua to 100
Glycerin 5
Paraffinium liquidurr 1 5 Dicaprylyl maleate 3
Petrolatum 3
Cetyl alcohol 2
Steareth-2 1.5 Glyceryl stearate 1.5
Steareth-21 1
Sodium citrate 0.06
Citric acid 0.02
Hydroxyethyl cellulose 0.3 Tetrasodium EDTA 0.05
Preservative qs
Parfum qs
Benzophenone 4 0.5
UV Protector See Table C
Method
Stage 1
EDTA, citric acid, sodium citrate and glycerin are dispersed in the water using stirring. For sample 1 , the hydroxyethyl cellulose is then added and hydrated using homogenisation for 5 minutes. The UV Protector and benzophenone 4 are added and dispersed with stirring. This phase was then heated to 70°C.
Stage 2 The oils and waxes are mixed in a separate vessel and heated to 70°C until melted.
Stage 3
The oil phase is added to the aqueous phase and an emulsion is formed using high shear homogenisation for 10 minutes. Stage 4
The emulsion is cooled to below 35°C using stirring. The preservative and perfume are then added and the product is made to weight with purified water.
The emulsion is stirred until cool and uniform.
Example 47 - Fluid Foundation
%w/w
Aqua to 100
Carbomer 941 0.5
Lanolin oil 5
Paraffinum liquidum 3.5
Stearyl alcohol (and) ceteareth-20 condensate 3
Triethanolamine 0.5
Ethanol 26
Tetrasodium EDTA 0.02
Pigments qs
Preservative qs
Benzophenone 4 0.5
UV protector See table C
Method
Stage 1
EDTA is added to the water and dispersed with stirring. The carbomer is added and hydrated using a homogeniser for 30 minutes and then the UV protector is added. This phase was then heated to 70°C.
Stage 2
The oil phase is mixed in a separate vessel and heated to 70°C until melted and uniform. Stage 3
The oil phase is added to the aqueous phase and an emulsion is formed using high shear homogenisation for 10 minutes. Sodium hydroxide is then added and the shear is maintained for a further 5 minutes. Maintaining the shear, the pigments and benzophenone 4 are slowly added and dispersed. The emulsion is sheared until uniform.
Stage 4
The emulsion is then cooled to below 35°C with stirring. The preservative is added and the product is made to weight with purified water.

Claims

1. Personal care compositions comprising:
(i) sunscreening compounds which are mycosprorine-like amino acids (MAAs) of formula I:
Figure imgf000073_0001
in which R-i is:
(a) H; or
(b) a group of formula II -CH(R2 )CH2OH (II) in which R2 is H or Me; or
(c) a group of formula III
-CH(R3)COOH (111) in which R3 is H or an alkyl group containing 1 to 3 carbon atoms optionally substituted by hydroxy or an ester thereof; or
(d) a group of formula IV
-CR4 = CHMe (IV) in which R4 is H or -COOH; and
R5 is methyl or a group of formula HI as defined above or an ester thereof; and (ii) an additional inorganic or organic sunscreening agent.
2. Personal care compositions as claimed in claim 1 wherein Ri is a group of formula HI and R3 is selected from H, -CH2OH, -CH(OH)Me and -CHMe2.
3. Personal care compositions as claimed in claim 1 or claim 2 wherein R5 is a group of formula III and R3 is H or -CH2OH.
4. Personal care compositions as claimed in any one of claims 1 to 3 wherein the mycosporine-like amino acid is selected from palythine, palythine serine, palythinol, asterina, mycosporine-2-glycine, shinorine, porphyra-334, N-methyl mycosporine serine, N-methyl mycosporine threonine, mycosporine-glycine valine, palythenic acid, usijirene and palythene.
5. Personal care compositions as claimed in any one of claims 1 to 4 wherein compositions contain 0.05 to 10% of the mycosporine-like amino acid by weight of the total composition.
6. Personal care compositions as claimed in any one of claims 1 to 5 wherein the additional inorganic or organic sunscreening agent is selected from: a) Microfine titanium dioxide; b) Microfine zinc oxide; and c) Boron nitride; d) Iron oxides; e) Talcs; f) para-aminobenzoic acids, esters and derivatives thereof; g) methoxycinnamate esters; h) benzophenones; i) dibenzoylmethanes; j) 2-phenylbenzimidazole-5-sulphonic acid and its salts and disodium phenyl dibenzimidazole tetrasulfonate; k) alkyl-β,β-diphenylacrylates;
I) triazines; m) camphor derivatives; n) organic pigments sunscreening agents; o) silicone based sunscreening agents; and p) salicylates.
7. Personal care compositions as claimed in claim 6 wherein the additional organic sunscreening agent is selected from 2-ethylhexyl para-dimethylamino- benzoate, the octyl ester of para-aminobenzoic acid, 2-ethylhexyl para- methoxycinnamate, 2-ethoxyethyl para-methoxycinnamate, α,β-di-(para- methoxycinnamoyl)-α'-(2-ethylhexanoyl)-glycerin, oxybenzone, 4-(tert-butyl-4'- methoxydibenzoylmethane, octocrylene, 2,4,6-trianilino-(p-carbo-2-ethylhexyl-1 '- oxy)-1 ,3,5 triazine, bis-octyloxyphenol methoxyphenyl triazine, methylbenzylidene camphor, terphthalylidene dicamphor sulfonic acid, methylene bis-benzotriazxole tetramethyl butylphenol, drometrizole trisiloxane, benzylidene malonate polysiloxane, dimethicodiethyl benzal malonate or octyl salicylate.
8. Use of a mycosporine-like amino acid of formula I as defined in any one of claims 1 to 3 in combination with an additional inorganic or organic sunscreening agent in the preparation of personal care compositions to provide protection to the user's skin or hair against the deleterious effects of UV radiation.
9. Use of a mycosporine-like amino acid of formula I as defined in any one of claims 1 to 3 in combination with an additional inorganic or organic sunscreening agent in the preparation of personal care compositions to protect the compositions from the deleterious effects of exposure of the composition to UV radiation.
10. Use of a mycosporine-like amino acid of formula I in combination with an additional inorganic or organic sunscreening agent as claimed in either claim 8 or claim 9 wherein the mycosporine-like amino acid is selected from palythine, palythine serine, palythinol, asterina, mycosporine-2-glycine, shinorine, porphyra- 334, N-methyl mycosporine serine, N-methyl mycosporine threonine, mycosporine-glycine valine, palythenic acid, usijirene and palythene.
11. Use of a mycosporine-like amino acid of formula I in combination with an additional inorganic or organic sunscreening agent as claimed in any one of claims 8 to 10 wherein the additional inorganic or organic sunscreening agent is selected from: a) Microfine titanium dioxide; b) Microfine zinc oxide; and c) Boron nitride; d) Iron oxides; e) Talcs; f) para-aminobenzoic acids, esters and derivatives thereof; g) methoxycinnamate esters; h) benzophenones; i) dibenzoylmethanes; j) 2-phenylbenzimidazole-5-sulphonic acid and its salts and disodium phenyl dibenzimidazole tetrasulfonate; k) alkyl-β,β-diphenylacrylates; I) triazines; m) camphor derivatives n) organic pigments sunscreening agents o) silicone based sunscreening agents; and p) salicylates.
12. Use of a mycosporine-like amino acid of formula I in combination with an additional inorganic or organic sunscreening agent as claimed in claim 11 wherein the additional organic sunscreening agent is selected from 2-ethylhexyl para-dimethylaminobenzoate, the octyl ester of para-aminobenzoic acid, 2- ethylhexyl para-methoxycinnamate, 2-ethoxyethyl para-methoxycinnamate, α,β-di- (para-methoxycinnamoyl)-α'-(2-ethylhexanoyl)-glycerin, oxybenzone, 4-(tert-butyl- 4'-methoxydibenzoylmethane, octocrylene, 2,4,6-trianilino-(p-carbo-2-ethylhexyl-1 '- oxy)-1 , 3, 5 triazine, bis-octyloxyphenol methoxyphenyl triazine, methylbenzylidene camphor, terphthalylidene dicamphor sulfonic acid, methylene bis-benzotriazxole tetramethyl butylphenol, drometrizole trisiloxane, benzylidene malonate polysiloxane, dimethicodiethyl benzal malonate or octyl salicylate.
13. Use of a mycosporine-like amino acid of formula I in combination with an additional inorganic or organic sunscreening agent as claimed in any of claims 8 to 12, wherein the personal care composition contains 0.05 to 10% by weight of the mycosporine-like amino acid and 0.1 to 25% by weight of the additional inorganic or organic sunscreening agent.
PCT/GB2001/005123 2000-11-17 2001-11-16 Personal care compositions WO2002039974A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01996358A EP1341514A1 (en) 2000-11-17 2001-11-16 Personal care compositions
AU2002223081A AU2002223081A1 (en) 2000-11-17 2001-11-16 Personal care compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0028161A GB0028161D0 (en) 2000-11-17 2000-11-17 Personal care compositions
GB0028161.8 2000-11-17

Publications (1)

Publication Number Publication Date
WO2002039974A1 true WO2002039974A1 (en) 2002-05-23

Family

ID=9903421

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/005123 WO2002039974A1 (en) 2000-11-17 2001-11-16 Personal care compositions

Country Status (4)

Country Link
EP (1) EP1341514A1 (en)
AU (1) AU2002223081A1 (en)
GB (1) GB0028161D0 (en)
WO (1) WO2002039974A1 (en)

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039508A1 (en) * 2001-11-07 2003-05-15 Beiersdorf Ag Low-viscosity, sprayable w/o emulsions
EP1473028A1 (en) * 2003-04-30 2004-11-03 Mibelle AG Cosmetic skin care products and cosmetic agents for protecting skin against premature aging
EP1479376A1 (en) * 2003-05-22 2004-11-24 Unilever Plc Personal product compositions comprising structured benefit agent pre-mix providing enhanced deposition of hydrophilic benefit agent
EP1479378A1 (en) * 2003-05-22 2004-11-24 Unilever Plc Personal product compositions comprising structured benefit agent pre-mix or delivery vehicle and providing enhanced effect of hydrophobic material seperate from the structured benefit agent
EP1479375A1 (en) * 2003-05-22 2004-11-24 Unilever Plc Nonbar personal product compositions comprising crystalline wax structured benefit agent pre-mix or delivery vehicle
JP2004346061A (en) * 2003-05-22 2004-12-09 Unilever Nv Body product composition containing structured useful agent premix or delivery vehicle
JP2005002100A (en) * 2003-05-22 2005-01-06 Unilever Nv Provision of composition for personal effect article containing structurizing effective agent premix or delivery medium, and of reinforcing effect of optical modifying agent separated from structurizing effective agent
JP2007016004A (en) * 2005-07-11 2007-01-25 Fisheries Research Agency Fibroblast growth accelerator
WO2007026035A2 (en) * 2005-08-31 2007-03-08 Universidad De Málaga Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant
WO2007026037A2 (en) * 2005-08-31 2007-03-08 Universidad De Málaga Use of a mixture of mycosporin-type amino acids (asterin 330 + palythine) as an antioxidant
WO2007026038A2 (en) * 2005-08-31 2007-03-08 Universidad De Málaga Use of a mycosporin-type amino acid (shinorine) as an antioxidant
WO2007026036A2 (en) * 2005-08-31 2007-03-08 Universidad De Málaga Use of a mycosporin-type amino acid (m-gly) as an antioxidant
ES2317741A1 (en) * 2006-06-20 2009-04-16 Universidad De Malaga Composition for solar protection based on algae and liquenes extracts. (Machine-translation by Google Translate, not legally binding)
WO2010091963A2 (en) 2009-01-29 2010-08-19 Basf Se Stabilization of cosmetic compositions
GB2472021A (en) * 2009-07-21 2011-01-26 Jurlique R & D Pty Ltd Cosmetic sunscreen composition
EP2308837A2 (en) 2004-08-03 2011-04-13 Protera S.R.L. Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
WO2011158041A2 (en) 2010-06-18 2011-12-22 The Boots Company Plc Topical composition
WO2013124784A1 (en) 2012-02-20 2013-08-29 Basf Se Enhancing the antimicrobial activity of biocides with polymers
FR3000894A1 (en) * 2013-01-17 2014-07-18 Gilbert Lab Composition used to protect degradation of deoxyribonucleic acid of epidermis cells, comprises synergistic combination of Porphyra umbilicalis extract and Karanja oil, carrier, hydrophilic/lipophilic UV screening agents, and pigments
US9234204B2 (en) 2012-08-07 2016-01-12 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
KR20170002587A (en) 2014-05-13 2017-01-06 각코우호우징 기타사토켄큐쇼 Method for producing mycosporine-like amino acid using microbes
WO2017013441A1 (en) * 2015-07-23 2017-01-26 King's College London Compositions and methods using palythine
JP2017519823A (en) * 2014-06-17 2017-07-20 トップジェニックス, インク.Topgenix, Inc. Topical formulation for UV protection
JP2017197475A (en) * 2016-04-27 2017-11-02 長瀬産業株式会社 Solution containing stabilized mycosporin-like amino acid, and method for producing the same
US9808415B2 (en) 2012-08-16 2017-11-07 Basf Se Polyoxyalkylene substituted alkylene diamines and their use on skin and hair
US10219990B2 (en) 2014-12-09 2019-03-05 Basf Se Solubilizing agents for UV filters in cosmetic formulations
EP3492144A1 (en) 2007-08-30 2019-06-05 Basf Se Stabilization of cosmetic compositions against photodegradation
JP2019524769A (en) * 2016-08-19 2019-09-05 ユニリーバー・ナームローゼ・ベンノートシヤープ Antibacterial composition
US10449135B2 (en) 2014-04-09 2019-10-22 Basf Se Solublizing agents for UV filters in cosmetic formulations
US10709645B2 (en) 2014-12-04 2020-07-14 Basf Se Microcapsules
WO2020094954A3 (en) * 2018-11-06 2020-07-16 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Method for assessing the ability of a substance or of a composition to prevent, slow or eliminate the signs of ageing of the skin or of the lips
JP2020114871A (en) * 2016-04-27 2020-07-30 長瀬産業株式会社 Solution containing stabilized mycosporin-like amino acid, and method for producing the same
US11046814B2 (en) 2016-10-05 2021-06-29 Basf Se Ultraviolet radiation absorbing polymer composition
WO2022008732A1 (en) 2020-07-10 2022-01-13 Basf Se Enhancing the activity of antimicrobial preservatives
JP2022017352A (en) * 2016-04-27 2022-01-25 長瀬産業株式会社 Solution comprising stabilized mycosporin-like amino acid and method for producing the same
CN113999525A (en) * 2021-10-28 2022-02-01 东莞市骏青电子科技有限公司 Anti-ultraviolet protection film and preparation method thereof
US11246817B2 (en) 2016-08-19 2022-02-15 Conopco, Inc. Antimicrobial composition
US11510854B2 (en) 2017-03-23 2022-11-29 Conopco, Inc. Hair care composition
WO2023281224A1 (en) * 2021-07-08 2023-01-12 Naos Institute Of Life Science Anti-sun cosmetic composition containing mycosporine-like amino acids
CN115768755A (en) * 2020-02-26 2023-03-07 爱尔克米亚公司 Method for synthesizing compounds absorbing ultraviolet radiation under flow conditions and formulations containing the same
US11793742B2 (en) 2014-04-11 2023-10-24 Basf Se Mixtures of cosmetic UV absorbers
WO2024028511A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved water resistance
WO2024027928A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved spf and uva photoprotection
WO2024027926A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition comprising a uv-filter stabilizer
WO2024027927A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved spf and uva photoprotection
WO2024027931A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Odor and colorant stabilized compositions
WO2024028513A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Odor and colorant stabilized compositions
WO2024028514A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved spf and uva photoprotection
WO2024028510A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved spf and uva photoprotection
WO2024028515A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition comprising a uv-filter stabilizer
WO2024028512A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Compositions comprising an antimicrobial boosting agent
WO2024027929A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved water resistance
WO2024027930A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Compositions comprising an antimicrobial boosting agent

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5762243A (en) * 1980-10-01 1982-04-15 Eisai Co Ltd Novel cyclohyxene compound and its preparation
JPS5849346A (en) * 1981-09-18 1983-03-23 Mitsubishi Chem Ind Ltd Mycosporine-based amino acid and its derivative
WO2000024369A1 (en) * 1998-10-23 2000-05-04 Nouvab Inc Solar radiation protection composition
FR2803200A1 (en) * 1999-12-30 2001-07-06 Brev Licences Et Commercialisa Topical cosmetic composition, useful for protecting skin and hair against sunlight, contains an extract from the red alga Polysiphonia lanosa

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5762243A (en) * 1980-10-01 1982-04-15 Eisai Co Ltd Novel cyclohyxene compound and its preparation
JPS5849346A (en) * 1981-09-18 1983-03-23 Mitsubishi Chem Ind Ltd Mycosporine-based amino acid and its derivative
WO2000024369A1 (en) * 1998-10-23 2000-05-04 Nouvab Inc Solar radiation protection composition
FR2803200A1 (en) * 1999-12-30 2001-07-06 Brev Licences Et Commercialisa Topical cosmetic composition, useful for protecting skin and hair against sunlight, contains an extract from the red alga Polysiphonia lanosa

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 198221, Derwent World Patents Index; AN 1982-42244e, XP002195350 *
DATABASE WPI Week 198318, Derwent World Patents Index; AN 1983-42354k, XP002195351 *

Cited By (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039508A1 (en) * 2001-11-07 2003-05-15 Beiersdorf Ag Low-viscosity, sprayable w/o emulsions
EP1473028A1 (en) * 2003-04-30 2004-11-03 Mibelle AG Cosmetic skin care products and cosmetic agents for protecting skin against premature aging
JP2004346062A (en) * 2003-05-22 2004-12-09 Unilever Nv Composition for body product containing structured useful agent premix or delivery vehicle and offering reinforcing effect of other hydrophobic material other than the structured useful agent
EP1479378A1 (en) * 2003-05-22 2004-11-24 Unilever Plc Personal product compositions comprising structured benefit agent pre-mix or delivery vehicle and providing enhanced effect of hydrophobic material seperate from the structured benefit agent
EP1479375A1 (en) * 2003-05-22 2004-11-24 Unilever Plc Nonbar personal product compositions comprising crystalline wax structured benefit agent pre-mix or delivery vehicle
JP2004346061A (en) * 2003-05-22 2004-12-09 Unilever Nv Body product composition containing structured useful agent premix or delivery vehicle
US7560125B2 (en) 2003-05-22 2009-07-14 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced deposition of hydrophilic benefit agent
JP2004346070A (en) * 2003-05-22 2004-12-09 Unilever Nv Non-rodlike personal product composition containing crystalline wax structured effective agent premix or delivery vehicle
JP2005002100A (en) * 2003-05-22 2005-01-06 Unilever Nv Provision of composition for personal effect article containing structurizing effective agent premix or delivery medium, and of reinforcing effect of optical modifying agent separated from structurizing effective agent
JP2005097244A (en) * 2003-05-22 2005-04-14 Unilever Nv Body product composition comprising premix or delivery vehicle of structured beneficial substance and promoting adhesion of hydrophilic beneficial substance
EP1479376A1 (en) * 2003-05-22 2004-11-24 Unilever Plc Personal product compositions comprising structured benefit agent pre-mix providing enhanced deposition of hydrophilic benefit agent
US7875582B2 (en) 2003-05-22 2011-01-25 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Nonbar personal product compositions comprising crystalline wax structured benefit agent premix or delivery vehicle
US7776346B2 (en) 2003-05-22 2010-08-17 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal product compositions comprising structured benefit agent premix or delivery vehicle
US7776347B2 (en) 2003-05-22 2010-08-17 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced effect of hydrophobic material separate from the structured benefit agent
EP2308837A2 (en) 2004-08-03 2011-04-13 Protera S.R.L. Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
JP2007016004A (en) * 2005-07-11 2007-01-25 Fisheries Research Agency Fibroblast growth accelerator
ES2307438A1 (en) * 2005-08-31 2008-11-16 Universidad De Malaga Use of a mixture of mycosporin-type amino acids (asterin 330 + palythine) as an antioxidant
ES2301428A1 (en) * 2005-08-31 2008-06-16 Universidad De Malaga Use of a mycosporin-type amino acid (shinorine) as an antioxidant
WO2007026035A3 (en) * 2005-08-31 2007-05-10 Univ Malaga Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant
ES2301293A1 (en) * 2005-08-31 2008-06-16 Universidad De Malaga Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant
WO2007026035A2 (en) * 2005-08-31 2007-03-08 Universidad De Málaga Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant
ES2301437A1 (en) * 2005-08-31 2008-06-16 Universidad De Malaga Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant
ES2301426A1 (en) * 2005-08-31 2008-06-16 Universidad De Malaga Use of a mycosporin-type amino acid (shinorine) as an antioxidant
WO2007026036A3 (en) * 2005-08-31 2007-05-10 Univ Malaga Use of a mycosporin-type amino acid (m-gly) as an antioxidant
ES2301438A1 (en) * 2005-08-31 2008-06-16 Universidad De Malaga Use of a mycosporin-type amino acid (m-gly) as an antioxidant
ES2301435A1 (en) * 2005-08-31 2008-06-16 Universidad De Malaga Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant
ES2303487A1 (en) * 2005-08-31 2008-08-01 Universidad De Malaga Use of a mixture of mycosporin-type amino acids (asterin 330 + palythine) as an antioxidant
ES2303412A1 (en) * 2005-08-31 2008-08-01 Universidad De Malaga Use of a mixture of mycosporin-type amino acids (asterin 330 + palythine) as an antioxidant
WO2007026038A3 (en) * 2005-08-31 2007-05-24 Univ Malaga Use of a mycosporin-type amino acid (shinorine) as an antioxidant
WO2007026037A3 (en) * 2005-08-31 2007-05-18 Univ Malaga Use of a mixture of mycosporin-type amino acids (asterin 330 + palythine) as an antioxidant
ES2301294A1 (en) * 2005-08-31 2008-06-16 Universidad De Malaga Use of a mycosporin-type amino acid (m-gly) as an antioxidant
WO2007026036A2 (en) * 2005-08-31 2007-03-08 Universidad De Málaga Use of a mycosporin-type amino acid (m-gly) as an antioxidant
WO2007026038A2 (en) * 2005-08-31 2007-03-08 Universidad De Málaga Use of a mycosporin-type amino acid (shinorine) as an antioxidant
WO2007026037A2 (en) * 2005-08-31 2007-03-08 Universidad De Málaga Use of a mixture of mycosporin-type amino acids (asterin 330 + palythine) as an antioxidant
ES2317741A1 (en) * 2006-06-20 2009-04-16 Universidad De Malaga Composition for solar protection based on algae and liquenes extracts. (Machine-translation by Google Translate, not legally binding)
EP3492144A1 (en) 2007-08-30 2019-06-05 Basf Se Stabilization of cosmetic compositions against photodegradation
WO2010091963A2 (en) 2009-01-29 2010-08-19 Basf Se Stabilization of cosmetic compositions
GB2472021A (en) * 2009-07-21 2011-01-26 Jurlique R & D Pty Ltd Cosmetic sunscreen composition
WO2011158041A2 (en) 2010-06-18 2011-12-22 The Boots Company Plc Topical composition
WO2013124784A1 (en) 2012-02-20 2013-08-29 Basf Se Enhancing the antimicrobial activity of biocides with polymers
EP3769624A2 (en) 2012-02-20 2021-01-27 Basf Se Enhancing the antimicrobial activity of biocides with polymers
US9453232B2 (en) 2012-08-07 2016-09-27 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
US9868957B2 (en) 2012-08-07 2018-01-16 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
US9234204B2 (en) 2012-08-07 2016-01-12 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
US9808415B2 (en) 2012-08-16 2017-11-07 Basf Se Polyoxyalkylene substituted alkylene diamines and their use on skin and hair
FR3000894A1 (en) * 2013-01-17 2014-07-18 Gilbert Lab Composition used to protect degradation of deoxyribonucleic acid of epidermis cells, comprises synergistic combination of Porphyra umbilicalis extract and Karanja oil, carrier, hydrophilic/lipophilic UV screening agents, and pigments
US10449135B2 (en) 2014-04-09 2019-10-22 Basf Se Solublizing agents for UV filters in cosmetic formulations
US11793742B2 (en) 2014-04-11 2023-10-24 Basf Se Mixtures of cosmetic UV absorbers
KR20170002587A (en) 2014-05-13 2017-01-06 각코우호우징 기타사토켄큐쇼 Method for producing mycosporine-like amino acid using microbes
US10307356B2 (en) 2014-05-13 2019-06-04 The Kitasato Institute Method for producing mycosporine-like amino acid using microbes
JP2017519823A (en) * 2014-06-17 2017-07-20 トップジェニックス, インク.Topgenix, Inc. Topical formulation for UV protection
US10064797B2 (en) 2014-06-17 2018-09-04 TopGeniX, Inc. Topical formulations for UV protection
US10709645B2 (en) 2014-12-04 2020-07-14 Basf Se Microcapsules
US10219990B2 (en) 2014-12-09 2019-03-05 Basf Se Solubilizing agents for UV filters in cosmetic formulations
WO2017013441A1 (en) * 2015-07-23 2017-01-26 King's College London Compositions and methods using palythine
JP2022017352A (en) * 2016-04-27 2022-01-25 長瀬産業株式会社 Solution comprising stabilized mycosporin-like amino acid and method for producing the same
JP2017197475A (en) * 2016-04-27 2017-11-02 長瀬産業株式会社 Solution containing stabilized mycosporin-like amino acid, and method for producing the same
JP7257479B2 (en) 2016-04-27 2023-04-13 長瀬産業株式会社 SOLUTION CONTAINING STABILIZED MYCOSPORIN-LIKE AMINO ACID, AND METHOD FOR PRODUCING SAME
JP2020114871A (en) * 2016-04-27 2020-07-30 長瀬産業株式会社 Solution containing stabilized mycosporin-like amino acid, and method for producing the same
US11246817B2 (en) 2016-08-19 2022-02-15 Conopco, Inc. Antimicrobial composition
JP2019524769A (en) * 2016-08-19 2019-09-05 ユニリーバー・ナームローゼ・ベンノートシヤープ Antibacterial composition
US11046814B2 (en) 2016-10-05 2021-06-29 Basf Se Ultraviolet radiation absorbing polymer composition
US11510854B2 (en) 2017-03-23 2022-11-29 Conopco, Inc. Hair care composition
WO2020094954A3 (en) * 2018-11-06 2020-07-16 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Method for assessing the ability of a substance or of a composition to prevent, slow or eliminate the signs of ageing of the skin or of the lips
CN112969920A (en) * 2018-11-06 2021-06-15 化工产品开发公司Seppic Method for evaluating the ability of a substance or composition to prevent, slow or eliminate the signs of skin or lip aging
CN115768755A (en) * 2020-02-26 2023-03-07 爱尔克米亚公司 Method for synthesizing compounds absorbing ultraviolet radiation under flow conditions and formulations containing the same
WO2022008732A1 (en) 2020-07-10 2022-01-13 Basf Se Enhancing the activity of antimicrobial preservatives
WO2023281224A1 (en) * 2021-07-08 2023-01-12 Naos Institute Of Life Science Anti-sun cosmetic composition containing mycosporine-like amino acids
FR3124945A1 (en) * 2021-07-08 2023-01-13 Naos Institute Of Life Science SUN COSMETIC COMPOSITION CONTAINING MYCOSPORIN ANALOG AMINO ACIDS
CN113999525A (en) * 2021-10-28 2022-02-01 东莞市骏青电子科技有限公司 Anti-ultraviolet protection film and preparation method thereof
CN113999525B (en) * 2021-10-28 2023-06-30 东莞市骏青电子科技有限公司 Ultraviolet-resistant protective film and preparation method thereof
WO2024028511A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved water resistance
WO2024027928A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved spf and uva photoprotection
WO2024027926A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition comprising a uv-filter stabilizer
WO2024027927A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved spf and uva photoprotection
WO2024027931A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Odor and colorant stabilized compositions
WO2024028513A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Odor and colorant stabilized compositions
WO2024028514A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved spf and uva photoprotection
WO2024028510A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved spf and uva photoprotection
WO2024028515A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition comprising a uv-filter stabilizer
WO2024028512A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Compositions comprising an antimicrobial boosting agent
WO2024027929A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Composition with improved water resistance
WO2024027930A1 (en) * 2022-08-05 2024-02-08 Symrise Ag Compositions comprising an antimicrobial boosting agent

Also Published As

Publication number Publication date
GB0028161D0 (en) 2001-01-03
AU2002223081A1 (en) 2002-05-27
EP1341514A1 (en) 2003-09-10

Similar Documents

Publication Publication Date Title
WO2002039974A1 (en) Personal care compositions
CA2602362C (en) Benzoic acid ester compounds, compositions, uses and methods related thereto
EP2455157B1 (en) Solubilizer for cosmetic preparations
US5141741A (en) Anti-sunburn skin-care preparation
EP3066068B1 (en) Hydroxytyrosol derivatives their method of preparation and use in personal care
BRPI9903600B1 (en) “Nanodispersion, its use, its pre-phase, and final cosmetic formulations”
EP1469822A2 (en) Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides
US5468474A (en) N-acylglutamine derivatives and cosmetic compositions
FR3013589A1 (en) COMPOSITION OF ALKYL POLYGLUCOSIDES AND CATIONED FATTY ACIDS
JP2568288B2 (en) N-alkoxyalkylamides and cosmetic treatment composition using the same
FR2597476A1 (en) BENZYLIDENIC COMPOUNDS, COMPOSITIONS CONTAINING SAME, AND ULTRAVIOLET RADIATION - ABSORBING AGENTS THEREOF.
US7544349B2 (en) Personal care compositions
JP4339136B2 (en) Topical skin preparation
JP4391293B2 (en) Ultraviolet absorber and external preparation for skin containing the same
JPH08325131A (en) Cosmetic
EP1416911B1 (en) Personal care compositions
EA030286B1 (en) Sunscreen composition
WO2010125092A1 (en) 3-dialkylaminophenyl 2-alkoxycarbonylbenzoic compounds
JP3504551B2 (en) External preparation for skin
JPH1171262A (en) Cosmetic
JPH07238275A (en) Ultraviolet light absorber and skin external preparation containing the same blended therein
JP3643167B2 (en) Topical skin preparation
JP2005015453A (en) Cosmetic composition containing isostearyl ferulate
JPH0873335A (en) Melanogenesis inhibitor and skin external preparation
JP2005289916A (en) Ultraviolet absorber and skin external preparation containing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001996358

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001996358

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP